Shares in Intersect ENT (NSDQ:XENT) have fallen slightly today despite the medical device maker released fourth quarter and full year 2018 earnings that met consensus expectations from analysts on Wall Street.
The Menlo Park, Calif.-based company posted losses of $5 million, or 16¢ per share, on sales of approximately $32.8 million for the three months ended December 31, seeing losses grow 59.6% while sales grew 11% compared with the same period during the previous year.
Read the whole story on our sister site Drug Delivery Business News
The post Intersect ENT shares dip despite street-beating Q4, 2018 earnings appeared first on MassDevice.
from MassDevice https://ift.tt/2Eelxz3
Cap comentari:
Publica un comentari a l'entrada